Related references
Note: Only part of the references are listed.Facioscapulohumeral muscular dystrophy: the road to targeted therapies
Mara S. S. Tihaya et al.
NATURE REVIEWS NEUROLOGY (2023)
CellMarker 2.0: an updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data
Congxue Hu et al.
NUCLEIC ACIDS RESEARCH (2023)
8C-like cells capture the human zygotic genome activation program in vitro
Jasmin Taubenschmid-Stowers et al.
CELL STEM CELL (2022)
Transient DUX4 expression in human embryonic stem cells induces blastomere-like expression program that is marked by SLC34A2
Masahito Yoshihara et al.
STEM CELL REPORTS (2022)
Dux facilitates post-implantation development, but is not essential for zygotic genome activation
Darko Bosnakovski et al.
BIOLOGY OF REPRODUCTION (2021)
The chromosomal protein SMCHD1 regulates DNA methylation and the 2c-like state of embryonic stem cells by antagonizing TET proteins
Zhijun Huang et al.
SCIENCE ADVANCES (2021)
Integrated analysis of multimodal single-cell data
Yuhan Hao et al.
CELL (2021)
p53 convergently activates Dux/DUX4 in embryonic stem cells and in facioscapulohumeral muscular dystrophy cell models
Edward J. Grow et al.
NATURE GENETICS (2021)
A transcriptional roadmap for 2C-like-to-pluripotent state transition
Xudong Fu et al.
SCIENCE ADVANCES (2020)
Dppa2 and Dppa4 directly regulate the Dux-driven zygotic transcriptional program
Melanie Eckersley-Maslin et al.
GENES & DEVELOPMENT (2019)
SMCHD1 is involved in de novo methylation of the DUX4-encoding D4Z4 macrosatellite
Camille Dion et al.
NUCLEIC ACIDS RESEARCH (2019)
Next-generation characterization of the Cancer Cell Line Encyclopedia
Mahmoud Ghandi et al.
NATURE (2019)
Loss of DUX causes minor defects in zygotic genome activation and is compatible with mouse development
Zhiyuan Chen et al.
NATURE GENETICS (2019)
SMCHD1 terminates the first embryonic genome activation event in mouse two-cell embryos and contributes to a transcriptionally repressive state
Meghan L. Ruebel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)
DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade
Guo-Liang Chew et al.
DEVELOPMENTAL CELL (2019)
Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy
Jonathan Oliva et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies
Steffen Boettcher et al.
SCIENCE (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Facioscapulohumeral dystrophy: activating an early embryonic transcriptional program in human skeletal muscle
Amy E. Campbell et al.
HUMAN MOLECULAR GENETICS (2018)
Protein kinase A activation inhibits DUX4 gene expression in myotubes from patients with facioscapulohumeral muscular dystrophy
Joseph M. Cruz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Identification of Epigenetic Regulators of DUX4-fl for Targeted Therapy of Facioscapulohumeral Muscular Dystrophy
Charis L. Himeda et al.
MOLECULAR THERAPY (2018)
NuRD and CAF-1-mediated silencing of the D4Z4 array is modulated by DUX4-induced MBD3L proteins
Amy E. Campbell et al.
ELIFE (2018)
SCANPY: large-scale single-cell gene expression data analysis
F. Alexander Wolf et al.
GENOME BIOLOGY (2018)
Intra-tumor heterogeneity from a cancer stem cell perspective
Pramudita R. Prasetyanti et al.
MOLECULAR CANCER (2017)
DUX-family transcription factors regulate zygotic genome activation in placental mammals
Alberto De Iaco et al.
NATURE GENETICS (2017)
Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL/HERVL retrotransposons
Peter G. Hendrickson et al.
NATURE GENETICS (2017)
Conservation and innovation in the DUX4-family gene network
Jennifer L. Whiddon et al.
NATURE GENETICS (2017)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
Massively parallel digital transcriptional profiling of single cells
Grace X. Y. Zheng et al.
NATURE COMMUNICATIONS (2017)
Defining a Cancer Dependency Map
Aviad Tsherniak et al.
CELL (2017)
Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults
Takahiko Yasuda et al.
NATURE GENETICS (2016)
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes
Si Ho Choi et al.
NUCLEIC ACIDS RESEARCH (2016)
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Maxim V. Kuleshov et al.
NUCLEIC ACIDS RESEARCH (2016)
MERVL/Zscan4 Network Activation Results in Transient Genome-wide DNA Demethylation of mESCs
Melanie A. Eckersley-Maslin et al.
CELL REPORTS (2016)
Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis
Jacob H. Levine et al.
CELL (2015)
Genetic and epigenetic contributors to FSHD
Lucia Daxinger et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2015)
Transient bursts of Zscan4 expression are accompanied by the rapid derepression of heterochromatin in mouse embryonic stem cells
Tomohiko Akiyama et al.
DNA RESEARCH (2015)
Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways
Amanda M. Rickard et al.
HUMAN MOLECULAR GENETICS (2015)
Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2
Richard J. L. F. Lemmers et al.
HUMAN MOLECULAR GENETICS (2015)
Facioscapulohumeral dystrophy: the path to consensus on pathophysiology
Rabi Tawil et al.
SKELETAL MUSCLE (2014)
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Edward Y. Chen et al.
BMC BIOINFORMATICS (2013)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
DUX4 Binding to Retroelements Creates Promoters That Are Active in FSHD Muscle and Testis
Janet M. Young et al.
PLOS GENETICS (2013)
Generation of Isogenic D4Z4 Contracted and Noncontracted Immortal Muscle Cell Clones from a Mosaic Patient A Cellular Model for FSHD
Yvonne D. Krom et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
DUX4 Activates Germ line Genes, Retroelements, and Immune Mediators: Implications for Facioscapulohumeral Dystrophy
Linda N. Geng et al.
DEVELOPMENTAL CELL (2012)
Mutant p53: one name, many proteins
William A. Freed-Pastor et al.
GENES & DEVELOPMENT (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
A Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy
Richard J. L. F. Lemmers et al.
SCIENCE (2010)
Facioscapulohumeral Dystrophy: Incomplete Suppression of a Retrotransposed Gene
Lauren Snider et al.
PLOS GENETICS (2010)
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
Ittai Ben-Porath et al.
NATURE GENETICS (2008)
Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes
A Willis et al.
ONCOGENE (2004)
Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy
PGM van Overveld et al.
NATURE GENETICS (2003)
Share Paper
